SCHEMBL22765224

SCHEMBL22765224

CNCc1ccc2cccc(NS(=O)(=O)c3cnn(C)c3)c2n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC40A1 Q9NP59 7/20 0.46
▸ GLO1 Q04760 5/20 0.46
▸ AGTR1 P30556 3/20 0.46
▸ PAX8 Q06710 2/20 0.46
▸ TDP1 Q9NUW8 4/20 0.45
▸ KMT2A Q03164 3/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ MMP2 P08253 1/20 0.41
▸ PLAU P00749 1/20 0.41
▸ MITF O75030 1/20 0.40
▸ S1PR4 O95977 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ S1PR1 P21453 1/20 0.40
▸ OPRK1 P41145 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ CKS1B P61024 1/20 0.40
▸ SKP2 Q13309 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22764870 0.87 SLC40A1 (0.46) SLC40A1GLO1AGTR1PAX8TDP1
SCHEMBL26053610 0.81 KMT2A (0.69) SLC40A1GLO1AGTR1PAX8TDP1
SCHEMBL22765113 0.80 TDP1 (0.54) SLC40A1GLO1AGTR1PAX8TDP1
SCHEMBL22765006 0.80 TDP1 (0.60) SLC40A1GLO1AGTR1PAX8TDP1
SCHEMBL30925490 0.79 SLC40A1 (0.64) SLC40A1GLO1AGTR1PAX8TDP1
SCHEMBL27214290 0.79 SLC40A1 (0.64) SLC40A1GLO1AGTR1PAX8TDP1
SCHEMBL22765075 0.78 GLO1 (0.67) SLC40A1GLO1AGTR1PAX8TDP1
SCHEMBL22764847 0.78 PLAU (0.53) SLC40A1GLO1AGTR1PAX8TDP1
SCHEMBL22764852 0.78 SLC40A1 (0.50) SLC40A1GLO1AGTR1PAX8TDP1
SCHEMBL22765051 0.77 SLC40A1 (0.63) SLC40A1GLO1AGTR1PAX8TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691949-B2 Quinoline sulfonamide compounds and their use as antibacterial agents OTAGO INNOVATION LIMITED (NZ) 2023-07-04 — — US disclosed
US-20200385354-A1 Quinoline Sulfonamide Compounds and Their Use as Antibacterial Agents OTAGO INNOVATION LIMITED (NZ) 2020-12-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11691949-B2 Quinoline sulfonamide compounds and their use as antibacterial agents NQO2, SDHA, SIRT5 SLC40A1 4081/4885GLO1 369/4885AGTR1 2065/4885
US-20200385354-A1 Quinoline Sulfonamide Compounds and Their Use as Antibacterial Agents NQO2, SDHA, SIRT5 SLC40A1 4081/4885GLO1 369/4885AGTR1 2065/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback